Efficacy of Diffusion-Weighted Imaging for the Differentiation between Lymphomas and Carcinomas of the Nasopharynx and Oropharynx: Correlations of Apparent Diffusion Coefficients and Histologic Features

References

1. 1.↵
   1. Sobin LH,
   2. Wittekind C

   eds. TNM Classification of Malignant Tumours. New York: Willey-Liss; 2002
2. 2.↵
   1. Sumi M,
   2. Sakihama N,
   3. Sumi T,
   4. et al

   . Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003;24: 1627–34

   Abstract/FREE Full Text
3. 3.↵
   1. Vandecaveye V,
   2. De Keyzer F,
   3. Vander Poorten V,
   4. et al

   . Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009;251: 134–46

   CrossRefPubMed
4. 4.↵
   1. Sumi M,
   2. Ichikawa Y,
   3. Nakamura T

   . Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol 2007;17: 2631–37

   CrossRefPubMed
5. 5.↵
   1. Barnes L,
   2. Eveson JW,
   3. Reichart P,
   4. et al.

   eds, Pathology and Genetics of Head and Neck Tumors; IARC WHO Classification of Tumours. Lyon: IARC Press; 2005
6. 6.↵
   1. Cohan DM,
   2. Popat S,
   3. Kaplan SE,
   4. et al

   . Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 2009;17: 88–94

   CrossRefPubMed
7. 7.↵
   1. Le Bihan D

   . Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003;4: 469–80

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Rosset A,
   2. Spadola L,
   3. Ratib O

   . OsiriX: an open-resource software for navigating in multidimensional DICOM images. J Digit Imaging 2004;17: 205–16

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Eida S,
   2. Sumi M,
   3. Sakihama N,
   4. et al

   . Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. AJNR Am J Neuroradiol 2007;28: 116–21

   Abstract/FREE Full Text
10. 10.↵
    1. Gordon AR,
    2. Loevner LA,
    3. Shukla-Dave A,
    4. et al

    . Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx. AJNR Am J Neuroradiol 2004;25: 1092–98

    Abstract/FREE Full Text
11. 11.↵
    1. Le Bihan D,
    2. Breton E,
    3. Lallemand D,
    4. et al

    . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161: 401–07

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Sumi M,
    2. Nakamura T

    . Diagnostic importance of focal defects in the apparent diffusion coefficient-based differentiation between lymphoma and squamous cell carcinoma nodes in the neck. Eur Radiol 2009;19: 975–81

    PubMed
13. 13.↵
    1. Hayat M

    1. Nakamura T,
    2. Sumi M,
    3. Van Cauteren M

    . Salivary gland tumors: preoperative tissue characterization with apparent diffusion coefficient mapping. In: Hayat M ed. Methods of Cancer Diagnosis, Therapy, and Prognosis, Vol. 2. New York: Springer-Verlag; 2010: 255–69
14. 14.↵
    1. Sumi M,
    2. Ichikawa Y,
    3. Katayama I,
    4. et al

    . Diffusion-weighted MR imaging of ameloblastomas and keratocystic odontogenic tumors: differentiation by apparent diffusion coefficients of cystic lesions. AJNR Am J Neuroradiol 2008;29: 1897–901. Epub 2008 Aug 21

    Abstract/FREE Full Text
15. 15.↵
    1. Le Bihan D

    . Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 2008;249: 748–52

    CrossRefPubMed
16. 16.↵
    1. Wei WI,
    2. Kwong DL

    . Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol 2010;1: 1–12